Technology News and Research

RSS

G-Zero receives NIAID's Phase II Small Business Innovation Research Grant

G-Zero Therapeutics, an RTP company started in 2008 based on technologies from the University of North Carolina at Chapel Hill, has been awarded a $3 million Phase II Small Business Innovation Research Grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

30 Sep 2011

Study provides insight into earliest stages of some cancers

A novel technique that enables scientists to measure and document tumor-inducing changes in DNA is providing new insight into the earliest events involved in the formation of leukemias, lymphomas and sarcomas, and could potentially lead to the discovery of ways to stop those events.

30 Sep 2011

Enrollment begins in Boston Scientific's vagal nerve stimulation trial for heart failure

Boston Scientific Corporation has enrolled the first patients in its NECTAR-HF (NEural Cardiac TherApy foR Heart Failure) clinical trial. NECTAR-HF is a prospective, randomized, international clinical feasibility study designed to assess preliminary safety and efficacy of chronic vagal nerve stimulation in heart failure patients.

30 Sep 2011

Two Influenza test kits receive FDA clearance for use in JBAIDS

Last week, the U.S. Army Office of the Surgeon General received Food and Drug Administration (FDA) clearance of two Influenza test kits for use on the Joint Biological Agent Identification and Diagnostic System.

30 Sep 2011

Circadian files IND with FDA for VGX-100 for the treatment of cancer patients with solid tumors

Circadian Technologies Limited (ASX: CIR, OTCQX:CKDXY) is extremely proud to announce that its 100% owned subsidiary, Vegenics Pty Ltd, has submitted an investigational new drug (IND) application to the U.S. Food and Drug Administration (FDA) to initiate clinical studies of VGX-100. The first trial (Phase I) will involve the treatment of a variety of different cancer types in patients with late stage cancer.

29 Sep 2011

New process makes linear peptides circular

Peptides and proteins have long been an attractive class of drug candidates because of their natural involvement in cellular processes and fewer potential side effects. Dr. Andrei Yudin, Professor, Department of Chemistry, University of Toronto, has developed a new and effective process that makes linear peptides circular, which allows these molecules, called macrocycles, to enter cells more effectively and increase their stability compared to linear peptides.

29 Sep 2011

Clinithink, Acusis to improve clinical documentation in ambulatory and acute care settings

Acusis, LLC and Clinithink Ltd. have agreed to collaborate with the initial goal of enhancing the clinical documentation process in ambulatory and acute care settings through the integration of Clinithink's new and transformative technology into the market-leading Acusis solution: AcuSuite.

29 Sep 2011

Rapid non-invasive test helps identify human exposure to potentially harmful substances

The search for a rapid, non-invasive way to determine whether people have been exposed to potentially toxic substances in their workplaces, homes and elsewhere in the environment has led scientists to a technology that literally takes a person's breath away.

29 Sep 2011

DSMB authorizes ACT to proceed with next set of patients in stem cell clinical trials

Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today that the independent Data and Safety Monitoring Board (DSMB) overseeing the Company's two ongoing stem cell clinical trials in the United States authorized ACT to move forward with enrolling and treating the next set of patients in each of the trials.

29 Sep 2011

Three papers reveal structure and workings of G protein-coupled receptors

Three international teams of scientists, led by researchers at the University of California San Diego, University of Michigan and Stanford University, have published a trio of papers describing in unprecedented detail the structure and workings of G protein-coupled receptors (GPCRs), a large family of human proteins that are the target of one-third to one-half of modern drugs.

29 Sep 2011

Low-tech, inexpensive interventions for bedsores could benefit long-term care residents

Researchers at the University of Toronto have found that low-tech, inexpensive interventions for bedsores could improve health for long-term care residents and reduce health-care costs for the facilities that house them.

29 Sep 2011

Study reports positive effect of RESPeRATE on CHF patients

InterCure Ltd., a medical device company publicly traded on the Tel-Aviv Stock Exchange, today announced that European Journal of Heart Failure, a peer reviewed medical journal of the European Society of Cardiology, published the results of a 72-patients, randomized, controlled study which demonstrated that device-guided respiratory modulation with RESPeRATE applied at the home setting can significantly relieve symptoms of heart failure in elderly patients.

29 Sep 2011

Study: Mammographic surveillance improves outcomes of breast cancer patients

New research published in Health Technology Assessment 2011; vol. 15:34 has found that surveillance using mammography increases the survival chances of breast cancer patients. The research was funded by the National Institute for Health Research Health Technology Assessment (NIHR HTA) programme.

29 Sep 2011

Simple low-cost method for isolation and collection of fragile prostate cancer cells

At the Oct. 2-6 microTAS 2011 conference, the premier international event for reporting research in microfluidics, nanotechnology and detection technologies for life science and chemistry, University of Cincinnati researchers will present a simple, low-cost, method for separating and safely collecting concentrated volumes of fragile prostate cancer cells.

29 Sep 2011

TD2 wins AZBio's Fast Lane award for economic development of Arizona biosciences

TGen Drug Development (TD2) won a Fast Lane award from the Arizona BioIndustry Association (AZBio) for promoting the economic development of Arizona biosciences.

29 Sep 2011

Calif. bill could affect out-patient surgery centers; some Florida public hospitals prosper

Also in news about local hospitals, the Mayo Clinic announces plans to develop a new medical school branch in Arizona and a Minn. hospital is accused of dumping a patient.

29 Sep 2011

DaTscan aids doctors in diagnosing patients with Parkinson's disease

Fifty thousand to 60,000 new cases of Parkinson's disease are diagnosed in the United States each year. Central DuPage Hospital (CDH) in Winfield, Ill., is among the first medical centers in North America to be using a new technology called DaTscan, an imaging tool that aids doctors in diagnosing patients who demonstrate Parkinsonian symptoms, like Parkinson's disease.

29 Sep 2011

DJO receives exclusive rights to sell Exos' range of upper extremity products

DJO Global, Inc., a leading global provider of medical device solutions for musculoskeletal health, vascular health and pain management, today announced that it has signed an exclusive distribution agreement with Exos Corporation, providing DJO with exclusive rights to sell Exos' broad range of upper extremity products that incorporate Exos' thermoformable polymer technology in North and South America.

28 Sep 2011

US researchers receive NIH grants to develop innovative neuroscience education programs

Eight investigators across the United States will receive funding over the next five years to develop innovative neuroscience education programs for K-12 students and their teachers. Activities described within some proposals include using touch tablet technology to teach neurobiology, and the creation of a 1,400-square-foot interactive learning center.

28 Sep 2011

XECAN's RFID Oncology Solution integrated with ThingMagic Astra UHF Reader

Trimble announced today that m, a leading provider of RFID patient safety solutions, has integrated the ThingMagic Astra UHF Reader into its RFID Oncology Solution. The XECAN solution enhances the patient experience and significantly assists in the goal of eliminating treatment errors allowing healthcare organizations to offer a safer and more inviting medical experience.

28 Sep 2011

Technology News and Research

G-Zero receives NIAID's Phase II Small Business Innovation Research Grant

Study provides insight into earliest stages of some cancers

Enrollment begins in Boston Scientific's vagal nerve stimulation trial for heart failure

Two Influenza test kits receive FDA clearance for use in JBAIDS

Circadian files IND with FDA for VGX-100 for the treatment of cancer patients with solid tumors

New process makes linear peptides circular

Clinithink, Acusis to improve clinical documentation in ambulatory and acute care settings

Rapid non-invasive test helps identify human exposure to potentially harmful substances

DSMB authorizes ACT to proceed with next set of patients in stem cell clinical trials

Three papers reveal structure and workings of G protein-coupled receptors

Low-tech, inexpensive interventions for bedsores could benefit long-term care residents

Study reports positive effect of RESPeRATE on CHF patients

Study: Mammographic surveillance improves outcomes of breast cancer patients

Simple low-cost method for isolation and collection of fragile prostate cancer cells

TD2 wins AZBio's Fast Lane award for economic development of Arizona biosciences

Calif. bill could affect out-patient surgery centers; some Florida public hospitals prosper

DaTscan aids doctors in diagnosing patients with Parkinson's disease

DJO receives exclusive rights to sell Exos' range of upper extremity products

US researchers receive NIH grants to develop innovative neuroscience education programs

XECAN's RFID Oncology Solution integrated with ThingMagic Astra UHF Reader

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News